Finally, we confirmed that the expression of mutant SPOP prolonged the half-life of endogenous ZMYND11 in VCaP cells and upregulated ZMYND11 expression in other prostate cancer cells (Fig. 4k and Supplementary Fig. 8b). This evidence concerns the gene SPOP and prostate cancer.